M&T Bank’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
11,972
-3,198
-21% -$328K ﹤0.01% 843
2026
Q1
$1.66M Sell
15,170
-1,830
-11% -$174K 0.01% 684
2025
Q4
$1.38M Sell
17,000
-8
-0% -$689 ﹤0.01% 754
2025
Q3
$1.49M Sell
17,008
-1,301
-7% -$116K 0.01% 662
2025
Q2
$1.52M Buy
18,309
+3,672
+25% +$307K 0.01% 709
2025
Q1
$1.23M Sell
14,637
-1,568
-10% -$146K ﹤0.01% 760
2024
Q4
$1.49M Sell
16,205
-494
-3% -$47.5K 0.01% 766
2024
Q3
$1.55M Buy
+16,699
New +$1.45M 0.01% 763

Other funds holding LMAT

M&T Bank's LMAT Position: Q2 2026 in Review

M&T Bank reduced its LeMaitre Vascular (LMAT) stake by 21% in Q2 2026, selling an estimated $328K and leaving 11,972 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #843.

M&T Bank first reported a position in LMAT in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.66M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • M&T Bank held 11,972 shares of LeMaitre Vascular worth $1.15M as of Q2 2026.
  • M&T Bank sold 3,198 LeMaitre Vascular shares in Q2 2026, an estimated $328K.
  • LeMaitre Vascular made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #843 holding.
  • M&T Bank first reported a position in LeMaitre Vascular in Q3 2024 and has held it in 8 quarters since.
  • M&T Bank's LeMaitre Vascular position peaked at $1.66M in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.